TwoStep Therapeutics
A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors.
$62.5MSeries A
Role not disclosedME
Medical Excellence Capital
Activity from announced rounds
All recorded activity
Medical Excellence Capital is the investment firm named in SonoThera and TwoStep financing histories.
Recorded funding activity
SonoThera develops ultrasound-mediated delivery of genetic medicines. TwoStep develops peptide-targeted therapies for solid tumors. These companies pursue different mechanisms of treatment, with uncertain financing roles preserved rather than inferred.
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $187.5M 2 disclosed · full round size, not this investor’s share